$EG

Everest Group (NYSE:EG) Misses Q2 CY2026 Sales Expectations

Everest Group (NYSE:EG) reported Q2 CY2026 revenue of $3.96 billion, down 11.8% year on year and below market expectations, according to the article. Non-GAAP EPS was $14.85, 2.2% above analysts’ consensus. The stock was reported flat at $393.38 after results.

Original reporting
Published Jul 29, 2026, 10:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 10:43 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Everest Group (NYSE:EG) Misses Q2 CY2026 Sales Expectations — source image
Decision brief

The 30-second read

$EGBearishMed
01

Why it matters

The key trading signal is the Q2 CY2026 revenue miss (down 11.8% YoY to $3.96B) despite a small non-GAAP EPS beat, implying weaker underwriting-related revenue momentum.

02

Market read

Traders may reprice near-term growth expectations and underwriting momentum based on the revenue shortfall, while monitoring whether BVPS strength persists.

03

What to watch

The article highlights net premiums earned as the dominant revenue driver (90.7% of revenue), but does not break out pricing vs volume, reserve development, or investment income drivers behind the revenue decline.

Relevance 7/10Novelty 6/10Timing: after-hours/just-reported Q2 CY2026 results, with the stock noted flat at $393.38 immediately after reporting

Background

Everest Group rebranded from Everest Re in 2023 and underwrites property and casualty reinsurance and insurance globally.

Company-level read

Ticker impact

$EGBearishMedium confidence
Context

Everest Group reported Q2 CY2026 revenue of $3.96B, down 11.8% YoY, missing Wall Street’s sales expectations.

Expected impact

Likely downside bias or continued underperformance versus peers until management clarifies drivers of the revenue decline.

Evidence & confidence

The article’s newest decision-relevant datapoint is the revenue miss (11.8% YoY to $3.96B) despite a small non-GAAP EPS beat, which typically weighs more on growth expectations for insurers.

Market effects

A revenue deceleration in a reinsurance/insurance underwriter can reinforce caution on underwriting momentum and pricing discipline across the sector.

No specific regional impact is disclosed in the article.

No explicit global macro or reinsurance catastrophe exposure details are provided beyond the company’s reported revenue decline.

Counterpoint

The non-GAAP EPS beat and improving BVPS trend could indicate earnings quality is holding up even if top-line premiums/revenue are temporarily pressured.

Key entities

  • Everest Group

    Global reinsurance and insurance underwriter reporting Q2 CY2026 revenue and EPS results.

Related articles

$EGMed

Everest (EG) Q2 2026 Earnings Call Transcript

Everest (EG) reported Q2 2026 earnings call results. It cited a combined ratio of 88.5% and underwriting income of $283 million, with gross written premium down about 9% YoY (constant dollars, excluding reinstatement). Property cat pricing fell about 10% between renewals, and Mount Logan Capital Management AUM was about $3.4B. Everest also said it repurchased $1.5B of shares since Jan 2025.

$EGMed

EVEREST GROUP, LTD. (EG): Results of Operations and Financial Condition

EVEREST GROUP, LTD. (EG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 everest2q26earningsrelease.htm EX-99.1 Document NEWS RELEASE EVEREST GROUP, LTD. Seon Place, 141 Front Street, 4 th Floor, Hamilton HM 19, Bermuda Contacts Media: Dawn Lauer Investors: Matt Rohrmann Chief Communications Officer Head of Investor Relations 908.300.7670 90

$EGMed

Everest Group, Ltd.: Everest and Stone Point Announce the Launch of Casualty Sidecar Annapurna Re Ltd; Stone Point Serves as Anchor Investor in Multi-Year Vehicle

Everest Group (NYSE: EG) and Stone Point Insurance Solutions announced the launch of Annapurna Re Ltd., a Bermuda-based casualty reinsurance sidecar. Stone Point funds will be the inaugural anchor investors in the multi-year vehicle, which is expected to deploy about $600 million of third-party capital over a three-year underwriting period to support Everest’s casualty and specialty portfolios.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.